{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:57:55Z","timestamp":1791388675399,"version":"4.3.3"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s43032-026-02191-8","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:39:35Z","timestamp":1789486775000},"page":"1931-1953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Biological Disease-Staging Model of Polyendocrine Metabolic Ovarian Syndrome: From Plasticity-Dominant States to Pathological Remodeling"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-6269","authenticated-orcid":false,"given":"Hiroshi","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2191_CR1","doi-asserted-by":"publisher","first-page":"e2298","DOI":"10.1210\/clinem\/dgae910","volume":"110","author":"AE Joham","year":"2025","unstructured":"Joham AE, Tay CT, Laven J, Louwers YV, Azziz R. Approach to the patient: diagnostic challenges in the workup for polycystic ovary syndrome. J Clin Endocrinol Metab. 2025;110:e2298\u2013308. https:\/\/doi.org\/10.1210\/clinem\/dgae910.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1055\/s-0041-1735259","volume":"39","author":"S Kiconco","year":"2021","unstructured":"Kiconco S, Teede HJ, Azziz R, Norman RJ, Joham AE. The need to reassess the diagnosis of polycystic ovary syndrome (PCOS): a review of diagnostic recommendations from the international evidence-based guideline for the assessment and management of PCOS. Semin Reprod Med. 2021;39:71\u20137. https:\/\/doi.org\/10.1055\/s-0041-1735259.","journal-title":"Semin Reprod Med"},{"key":"2191_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21:230\u201344. https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat Rev Endocrinol"},{"key":"2191_CR4","doi-asserted-by":"publisher","unstructured":"Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407:2329\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(26)00717-8.","DOI":"10.1016\/S0140-6736(26)00717-8"},{"key":"2191_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"key":"2191_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2012.10.009","volume":"373","author":"G Kosova","year":"2013","unstructured":"Kosova G, Urbanek M. Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:29\u201338. https:\/\/doi.org\/10.1016\/j.mce.2012.10.009.","journal-title":"Mol Cell Endocrinol"},{"key":"2191_CR7","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-24-0269","volume":"265","author":"EJ Houston","year":"2025","unstructured":"Houston EJ, Templeman NM. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. J Endocrinol. 2025;265:e240269. https:\/\/doi.org\/10.1530\/JOE-24-0269.","journal-title":"J Endocrinol"},{"key":"2191_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31:2619\u201331. https:\/\/doi.org\/10.1093\/humrep\/dew243.","journal-title":"Hum Reprod"},{"key":"2191_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.fertnstert.2025.08.023","volume":"124","author":"J Laven","year":"2025","unstructured":"Laven J. Polycystic ovary syndrome: antimullerian hormone and its role in the pathophysiology of the syndrome. Fertil Steril. 2025;124:910\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.08.023.","journal-title":"Fertil Steril"},{"key":"2191_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne). 2022;13:1091147. https:\/\/doi.org\/10.3389\/fendo.2022.1091147.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111575","volume":"127","author":"Y Ma","year":"2025","unstructured":"Ma Y, Ma Y, Li P, Ma F, Yu M, Xu J, et al. Wnt5a alleviates the symptoms of PCOS by modulating PI3K\/AKT\/mTOR pathway-mediated autophagy in granulosa cells. Cell Signal. 2025;127:111575. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111575.","journal-title":"Cell Signal"},{"key":"2191_CR12","doi-asserted-by":"publisher","first-page":"11905","DOI":"10.18632\/oncotarget.24190","volume":"9","author":"X Song","year":"2018","unstructured":"Song X, Shen Q, Fan L, Yu Q, Jia X, Sun Y, et al. Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome. Oncotarget. 2018;9:11905\u201321. https:\/\/doi.org\/10.18632\/oncotarget.24190.","journal-title":"Oncotarget"},{"key":"2191_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1757-2215-5-38","volume":"5","author":"A Yaba","year":"2012","unstructured":"Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res. 2012;5:38. https:\/\/doi.org\/10.1186\/1757-2215-5-38.","journal-title":"J Ovarian Res"},{"key":"2191_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083923","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Nikiforov NG, Eid AH, Nedosugova LV, Starodubova AV, Popkova TV, et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci. 2021;22:3923. https:\/\/doi.org\/10.3390\/ijms22083923.","journal-title":"Int J Mol Sci"},{"key":"2191_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911384","volume":"23","author":"Q Yao","year":"2022","unstructured":"Yao Q, Zou X, Liu S, Wu H, Shen Q, Kang J. Oxidative stress as a contributor to insulin resistance in the skeletal muscles of mice with polycystic ovary syndrome. Int J Mol Sci. 2022;23:11384. https:\/\/doi.org\/10.3390\/ijms231911384.","journal-title":"Int J Mol Sci"},{"key":"2191_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031172","volume":"26","author":"H Kobayashi","year":"2025","unstructured":"Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S. A comprehensive review of the contribution of mitochondrial DNA mutations and dysfunction in polycystic ovary syndrome, supported by secondary database analysis. Int J Mol Sci. 2025;26:1172. https:\/\/doi.org\/10.3390\/ijms26031172.","journal-title":"Int J Mol Sci"},{"key":"2191_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jog.15916","volume":"50","author":"H Kobayashi","year":"2024","unstructured":"Kobayashi H, Shigetomi H, Matsubara S, Yoshimoto C, Imanaka S. Role of the mitophagy-apoptosis axis in the pathogenesis of polycystic ovarian syndrome. J Obstet Gynaecol Res. 2024;50:775\u201392. https:\/\/doi.org\/10.1111\/jog.15916.","journal-title":"J Obstet Gynaecol Res"},{"key":"2191_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30:214\u201326. https:\/\/doi.org\/10.1016\/j.molcel.2008.03.003.","journal-title":"Mol Cell"},{"key":"2191_CR19","unstructured":"Kobayashi H, Shigetomi H, Nishio M, Umetani M, Imanaka S, Hashimoto H. Molecular Mechanisms Underlying Reproductive Dysfunction in Polycystic Ovary Syndrome. Reprod Sci (accepted, in press)."},{"key":"2191_CR20","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/ijms24043140","volume":"24","author":"R Herman","year":"2023","unstructured":"Herman R, Sikonja J, Jensterle M, Janez A, Dolzan V. Insulin metabolism in polycystic ovary syndrome: secretion, signaling, and clearance. Int J Mol Sci. 2023;24:3140. https:\/\/doi.org\/10.3390\/ijms24043140.","journal-title":"Int J Mol Sci"},{"key":"2191_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034.","journal-title":"Endocr Rev"},{"key":"2191_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000184145","volume":"42","author":"JF Cara","year":"1994","unstructured":"Cara JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res. 1994;42:49\u201354. https:\/\/doi.org\/10.1159\/000184145.","journal-title":"Horm Res"},{"key":"2191_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.fertnstert.2022.01.014","volume":"117","author":"J van Keizerswaard","year":"2022","unstructured":"van Keizerswaard J, Dietz de Loos ALP, Louwers YV, Laven JSE. Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study. Fertil Steril. 2022;117:1059\u201366. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.01.014.","journal-title":"Fertil Steril"},{"key":"2191_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/pjog.pjog_49_24","volume":"48","author":"M Mohapatra, Ipsita","year":"2024","unstructured":"Mohapatra, Ipsita M, Ranjan SS. Age matters: Demographic insights into polycystic ovarian syndrome across generations. Philippine J Obstet Gynecol. 2024;48:162\u20137. https:\/\/doi.org\/10.4103\/pjog.pjog_49_24.","journal-title":"Philippine J Obstet Gynecol"},{"key":"2191_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4755-12-7","volume":"12","author":"AS Jamil","year":"2015","unstructured":"Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Reprod Health. 2015;12:7. https:\/\/doi.org\/10.1186\/1742-4755-12-7.","journal-title":"Reprod Health"},{"key":"2191_CR26","doi-asserted-by":"publisher","first-page":"e16152","DOI":"10.1111\/jog.16152","volume":"51","author":"H Noguchi","year":"2025","unstructured":"Noguchi H, Iwase A, Iwasa T, Kanasaki H, Kimura F, Kugu K, et al. from the subcommittee Validation of diagnostic criteria for polycystic ovary syndrome in Japan in Reproductive Endocrine Committee, Japan Society of Obstetrics and Gynecology. Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria. J Obstet Gynaecol Res. 2025;51:e16152. https:\/\/doi.org\/10.1111\/jog.16152.","journal-title":"J Obstet Gynaecol Res"},{"key":"2191_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0043-1775835","volume":"41","author":"CT Tay","year":"2023","unstructured":"Tay CT, Khomami MB. Broadening the scope of polycystic ovary syndrome (PCOS) care: insights from the 2023 international evidence-based PCOS guideline. Semin Reprod Med. 2023;41:3\u20134. https:\/\/doi.org\/10.1055\/s-0043-1775835.","journal-title":"Semin Reprod Med"},{"key":"2191_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al.; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u201388. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035.","journal-title":"Fertil Steril"},{"key":"2191_CR29","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91:2100\u20134. https:\/\/doi.org\/10.1210\/jc.2005-1494.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/jcmm.17139","volume":"26","author":"M Tamaddon","year":"2022","unstructured":"Tamaddon M, Azimzadeh M, Tavangar SM. microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome. J Cell Mol Med. 2022;26:654\u201370. https:\/\/doi.org\/10.1111\/jcmm.17139.","journal-title":"J Cell Mol Med"},{"key":"2191_CR31","doi-asserted-by":"publisher","first-page":"e27286","DOI":"10.1371\/journal.pone.0027286","volume":"6","author":"N Xu","year":"2011","unstructured":"Xu N, Kwon S, Abbott DH, Geller DH, Dumesic DA, Azziz R, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS ONE. 2011;6:e27286. https:\/\/doi.org\/10.1371\/journal.pone.0027286.","journal-title":"PLoS ONE"},{"key":"2191_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021;33:513-30.e8. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.004.","journal-title":"Cell Metab"},{"key":"2191_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1740001","volume":"174","author":"DH Abbott","year":"2002","unstructured":"Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol. 2002;174:1\u20135. https:\/\/doi.org\/10.1677\/joe.0.1740001.","journal-title":"J Endocrinol"},{"key":"2191_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","volume":"14","author":"DH Abbott","year":"2019","unstructured":"Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab. 2019;14:131\u201343. https:\/\/doi.org\/10.1080\/17446651.2019.1576522.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2191_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","volume":"145","author":"MO Goodarzi","year":"2015","unstructured":"Goodarzi MO, Carmina E, Azziz R. DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol. 2015;145:213\u201325. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.003.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2191_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020302","volume":"13","author":"R Heidarzadehpilehrood","year":"2022","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Binti Osman M, Sakinah M, Nordin N, et al. A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes (Basel). 2022;13:302. https:\/\/doi.org\/10.3390\/genes13020302.","journal-title":"Genes (Basel)"},{"key":"2191_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104.","journal-title":"Endocr Rev"},{"key":"2191_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053089","volume":"19","author":"A Szeliga","year":"2022","unstructured":"Szeliga A, Rudnicka E, Maciejewska-Jeske M, Kucharski M, Kostrzak A, Hajbos M, et al. Neuroendocrine determinants of polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19:3089. https:\/\/doi.org\/10.3390\/ijerph19053089.","journal-title":"Int J Environ Res Public Health"},{"key":"2191_CR39","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/jc.2004-2359","volume":"90","author":"S Chhabra","year":"2005","unstructured":"Chhabra S, McCartney CR, Yoo RY, Eagleson CA, Chang RJ, Marshall JC. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J Clin Endocrinol Metab. 2005;90:2810\u20135. https:\/\/doi.org\/10.1210\/jc.2004-2359.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR40","doi-asserted-by":"publisher","first-page":"e13093","DOI":"10.1111\/jne.13093","volume":"34","author":"CR McCartney","year":"2022","unstructured":"McCartney CR, Campbell RE, Marshall JC, Moenter SM. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome. J Neuroendocrinol. 2022;34:e13093. https:\/\/doi.org\/10.1111\/jne.13093.","journal-title":"J Neuroendocrinol"},{"key":"2191_CR41","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","volume":"14","author":"G Pratama","year":"2024","unstructured":"Pratama G, Wiweko B, Asmarinah, Widyahening IS, Andraini T, Bayuaji H, et al. Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis. Sci Rep. 2024;14:8229. https:\/\/doi.org\/10.1038\/s41598-024-58064-0.","journal-title":"Sci Rep"},{"key":"2191_CR42","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149:R219\u201327. https:\/\/doi.org\/10.1530\/REP-14-0435.","journal-title":"Reproduction"},{"key":"2191_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115470","volume":"167","author":"Y Feng","year":"2023","unstructured":"Feng Y, Tang Z, Zhang W. The role of macrophages in polycystic ovarian syndrome and its typical pathological features: a narrative review. Biomed Pharmacother. 2023;167:115470. https:\/\/doi.org\/10.1016\/j.biopha.2023.115470.","journal-title":"Biomed Pharmacother"},{"key":"2191_CR44","doi-asserted-by":"publisher","unstructured":"Yang W, Pang N, He X. Breaking the metabolic-inflammatory vicious cycle in polycystic ovary syndrome: a comparative review of ketogenic and high-fat diets. Lipids Health Dis. 20256;24:310. https:\/\/doi.org\/10.1186\/s12944-025-02693-5.","DOI":"10.1186\/s12944-025-02693-5"},{"key":"2191_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ncpendmet0190","volume":"2","author":"M Roden","year":"2006","unstructured":"Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes\u2013pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab. 2006;2:335\u201348. https:\/\/doi.org\/10.1038\/ncpendmet0190.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2191_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y. Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol (Lausanne). 2021;12:667422. https:\/\/doi.org\/10.3389\/fendo.2021.667422.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. 2025;23:443. https:\/\/doi.org\/10.1186\/s12967-025-06315-7.","journal-title":"J Transl Med"},{"key":"2191_CR48","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1038\/s41598-025-92006-8","volume":"15","author":"Y Bai","year":"2025","unstructured":"Bai Y, Chang H, Tang N, Zhou H, Wang X, Shen K, et al. Micronutrients and polycystic ovary syndrome in the IEU OpenGWAS project: a two-Sample unidirectional Mendelian randomization analysis. Sci Rep. 2025;15:9721. https:\/\/doi.org\/10.1038\/s41598-025-92006-8.","journal-title":"Sci Rep"},{"key":"2191_CR49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/09513590.2020.1751111","volume":"36","author":"A Bizo\u0144","year":"2020","unstructured":"Bizo\u0144 A, S\u0142owiak A, Franik G, Biernacka-Bartnik A, Madej P. Zinc, copper, sirtuin 1 concentration, and glucose metabolism parameters in the blood of women with polycystic ovary syndrome. Gynecol Endocrinol. 2020;36:951\u20134. https:\/\/doi.org\/10.1080\/09513590.2020.1751111.","journal-title":"Gynecol Endocrinol"},{"key":"2191_CR50","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.3390\/jcm11092548","volume":"11","author":"A Bizo\u0144","year":"2022","unstructured":"Bizo\u0144 A, Tch\u00f3rz A, Madej P, Le\u015bniewski M, W\u00f3jtowicz M, Piwowar A, et al. The activity of superoxide dismutase, its relationship with the concentration of zinc and copper and the prevalence of rs2070424 superoxide dismutase gene in women with polycystic ovary syndrome-preliminary study. J Clin Med. 2022;11:2548. https:\/\/doi.org\/10.3390\/jcm11092548.","journal-title":"J Clin Med"},{"key":"2191_CR51","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1210\/jc.2017-02459","volume":"103","author":"J Qi","year":"2018","unstructured":"Qi J, Wang W, Zhu Q, He Y, Lu Y, Wang Y, et al. Local cortisol elevation contributes to endometrial insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103:2457\u201367. https:\/\/doi.org\/10.1210\/jc.2017-02459.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR52","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s00125-004-1662-6","volume":"48","author":"M Ueno","year":"2005","unstructured":"Ueno M, Carvalheira JB, Tambascia RC, Bezerra RM, Amaral ME, Carneiro EM, et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1\/2 serine phosphorylation and the mTOR\/p70 S6K pathway. Diabetologia. 2005;48:506\u201318. https:\/\/doi.org\/10.1007\/s00125-004-1662-6.","journal-title":"Diabetologia"},{"key":"2191_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/me.2009-0328","volume":"24","author":"A Veilleux","year":"2010","unstructured":"Veilleux A, Houde VP, Bellmann K, Marette A. Chronic inhibition of the mTORC1\/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Mol Endocrinol. 2010;24:766\u201378. https:\/\/doi.org\/10.1210\/me.2009-0328.","journal-title":"Mol Endocrinol"},{"key":"2191_CR54","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","volume":"24","author":"D Javelaud","year":"2005","unstructured":"Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene. 2005;24:5742\u201350. https:\/\/doi.org\/10.1038\/sj.onc.1208928.","journal-title":"Oncogene"},{"key":"2191_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00446-7","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol. 2023;12:83. https:\/\/doi.org\/10.1186\/s40164-023-00446-7.","journal-title":"Exp Hematol Oncol"},{"key":"2191_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20:888\u201399. https:\/\/doi.org\/10.1038\/s41556-018-0142-z.","journal-title":"Nat Cell Biol"},{"key":"2191_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03519-7","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S. RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential. Cancer Cell Int. 2024;24:339. https:\/\/doi.org\/10.1186\/s12935-024-03519-7.","journal-title":"Cancer Cell Int"},{"key":"2191_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115415","volume":"166","author":"M Liu","year":"2023","unstructured":"Liu M, Wu K, Wu Y. The emerging role of ferroptosis in female reproductive disorders. Biomed Pharmacother. 2023;166:115415. https:\/\/doi.org\/10.1016\/j.biopha.2023.115415.","journal-title":"Biomed Pharmacother"},{"key":"2191_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tem.2023.08.005","volume":"34","author":"SH Myers","year":"2023","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V. Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab. 2023;34:694\u2013703. https:\/\/doi.org\/10.1016\/j.tem.2023.08.005.","journal-title":"Trends Endocrinol Metab"},{"key":"2191_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/metabo16040277","volume":"16","author":"MLA Cepero-Gonz\u00e1lez","year":"2026","unstructured":"Cepero-Gonz\u00e1lez MLA, Aguilar-Galarza A, Rodr\u00edguez-Garc\u00eda VM, Garc\u00eda-Gasca T, Moreno Celis U. Diagnostic criteria and genetic basis of polycystic ovary syndrome: a narrative review. Metabolites. 2026;16:277. https:\/\/doi.org\/10.3390\/metabo16040277.","journal-title":"Metabolites"},{"key":"2191_CR61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","volume":"293","author":"AS Jamil","year":"2016","unstructured":"Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet. 2016;293:447\u201356. https:\/\/doi.org\/10.1007\/s00404-015-3889-5.","journal-title":"Arch Gynecol Obstet"},{"key":"2191_CR62","doi-asserted-by":"publisher","first-page":"bvaf199","DOI":"10.1210\/jendso\/bvaf199","volume":"10","author":"PJ Schwenck-Carvalho","year":"2025","unstructured":"Schwenck-Carvalho PJ, Maffazioli GN, Sim\u00f5es RS, Macchione RF, de Medeiros SF, Soares J\u00fanior JM, et al. Anti-Mullerian hormone levels across phenotypes in polycystic ovary syndrome: a systematic review and meta-analysis. J Endocr Soc. 2025;10:bvaf199. https:\/\/doi.org\/10.1210\/jendso\/bvaf199.","journal-title":"J Endocr Soc"},{"key":"2191_CR63","doi-asserted-by":"publisher","first-page":"e250226","DOI":"10.1530\/JOE-25-0226","volume":"267","author":"YC Ma","year":"2025","unstructured":"Ma YC, Law KS, Wang WS, Chang HM. Phenotypic variations in polycystic ovary syndrome: metabolic risks and emerging biomarkers. J Endocrinol. 2025;267:e250226. https:\/\/doi.org\/10.1530\/JOE-25-0226.","journal-title":"J Endocrinol"},{"key":"2191_CR64","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1210\/clinem\/dgae298","volume":"109","author":"K van der Ham","year":"2024","unstructured":"van der Ham K, Moolhuijsen LME, Brewer K, Sisk R, Dunaif A, Laven JSE, et al. Clustering identifies subtypes with different phenotypic characteristics in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2024;109:3096\u2013107. https:\/\/doi.org\/10.1210\/clinem\/dgae298.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","volume":"50","author":"S Chang","year":"2021","unstructured":"Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome: which criteria to use and when? Endocrinol Metab Clin North Am. 2021;50:11\u201323. https:\/\/doi.org\/10.1016\/j.ecl.2020.10.002.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2191_CR66","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41591-025-03984-1","volume":"31","author":"X Gao","year":"2025","unstructured":"Gao X, Zhao S, Du Y, Yang Z, Tian Y, Zhao J, et al. Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes. Nat Med. 2025;31:4214\u201324. https:\/\/doi.org\/10.1038\/s41591-025-03984-1.","journal-title":"Nat Med"},{"key":"2191_CR67","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2019.03.011","volume":"221","author":"Y He","year":"2019","unstructured":"He Y, Lu Y, Zhu Q, Wang Y, Lindheim SR, Qi J, et al. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol. 2019;221:138.e1-138.e12. https:\/\/doi.org\/10.1016\/j.ajog.2019.03.011.","journal-title":"Am J Obstet Gynecol"},{"key":"2191_CR68","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.108789","volume":"16","author":"N Rambaran","year":"2025","unstructured":"Rambaran N, Islam MS. Decoding androgen excess in polycystic ovary syndrome: roles of insulin resistance and other key intraovarian and systemic factors. World J Diabetes. 2025;16:108789. https:\/\/doi.org\/10.4239\/wjd.v16.i7.108789.","journal-title":"World J Diabetes"},{"key":"2191_CR69","doi-asserted-by":"publisher","first-page":"105829","DOI":"10.1016\/j.jsbmb.2021.105829","volume":"208","author":"P Cui","year":"2021","unstructured":"Cui P, Hu W, Ma T, Hu M, Tong X, Zhang F, et al. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats. J Steroid Biochem Mol Biol. 2021;208:105829. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105829.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2191_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00692","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Yu Q. Role of mTOR signaling in female reproduction. Front Endocrinol (Lausanne). 2019;10:692. https:\/\/doi.org\/10.3389\/fendo.2019.00692.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR71","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcp.30613","volume":"237","author":"JK Bhardwaj","year":"2022","unstructured":"Bhardwaj JK, Paliwal A, Saraf P, Sachdeva SN. Role of autophagy in follicular development and maintenance of primordial follicular pool in the ovary. J Cell Physiol. 2022;237:1157\u201370. https:\/\/doi.org\/10.1002\/jcp.30613.","journal-title":"J Cell Physiol"},{"key":"2191_CR72","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","volume":"17","author":"S Kumariya","year":"2021","unstructured":"Kumariya S, Ubba V, Jha RK, Gayen JR. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy. 2021;17:2706\u201333. https:\/\/doi.org\/10.1080\/15548627.2021.1938914.","journal-title":"Autophagy"},{"key":"2191_CR73","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.3390\/ijms22158149","volume":"22","author":"A Cayo","year":"2021","unstructured":"Cayo A, Segovia R, Venturini W, Moore-Carrasco R, Valenzuela C, Brown N. mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership. Int J Mol Sci. 2021;22:8149. https:\/\/doi.org\/10.3390\/ijms22158149.","journal-title":"Int J Mol Sci"},{"key":"2191_CR74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/09513590.2011.583955","volume":"28","author":"A Makker","year":"2012","unstructured":"Makker A, Goel MM, Das V, Agarwal A. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol. 2012;28:175\u201381. https:\/\/doi.org\/10.3109\/09513590.2011.583955.","journal-title":"Gynecol Endocrinol"},{"key":"2191_CR75","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s43032-019-00026-3","volume":"27","author":"L Or\u00f3stica","year":"2020","unstructured":"Or\u00f3stica L, Poblete C, Romero C, Vega M. Pro-inflammatory markers negatively regulate IRS1 in endometrial cells and endometrium from women with obesity and PCOS. Reprod Sci. 2020;27:290\u2013300. https:\/\/doi.org\/10.1007\/s43032-019-00026-3.","journal-title":"Reprod Sci"},{"key":"2191_CR76","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121:179\u201393. https:\/\/doi.org\/10.1016\/j.cell.2005.02.031.","journal-title":"Cell"},{"key":"2191_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/genes17020121","volume":"17","author":"S Chen","year":"2026","unstructured":"Chen S, Lu J, Si Y, Chen L, Zhao Y, Niu L, et al. The role and mechanisms of miRNAs on ovarian granulosa cells: a literature review. Genes (Basel). 2026;17:121. https:\/\/doi.org\/10.3390\/genes17020121.","journal-title":"Genes (Basel)"},{"key":"2191_CR78","doi-asserted-by":"publisher","first-page":"1501306","DOI":"10.3389\/fendo.2024.1501306","volume":"15","author":"M Rojo","year":"2025","unstructured":"Rojo M, P\u00e9rez H, Mill\u00e1n AL, Pautasso MC, Duarte A, Abruzzese GA, et al. Mitochondrial DNA oxidation and content in different metabolic phenotypes of women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2025;15:1501306. https:\/\/doi.org\/10.3389\/fendo.2024.1501306.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ijgo.16057","volume":"169","author":"K Peng","year":"2025","unstructured":"Peng K, Han X, Wu C, Lu Q, Gao S. The mitochondrial DNA copy number and ovary-related reproductive disorders: A bidirectional two-sample Mendelian randomization study. Int J Gynaecol Obstet. 2025;169:112\u201320. https:\/\/doi.org\/10.1002\/ijgo.16057.","journal-title":"Int J Gynaecol Obstet"},{"key":"2191_CR80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2025.09.025","volume":"241","author":"M Pelech\u00e1-Salvador","year":"2025","unstructured":"Pelech\u00e1-Salvador M, M\u00e1rquez-Arrico CF, Fern\u00e1ndez-Reyes M, Perea-Galera L, Hermenejildo J, Morillas C, et al. Autophagy and mitophagy in circulating immune cells of women with polycystic ovary syndrome: A cardiovascular perspective. Free Radic Biol Med. 2025;241:161\u201370. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.025.","journal-title":"Free Radic Biol Med"},{"key":"2191_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10815-022-02676-w","volume":"40","author":"S Mazloomi","year":"2023","unstructured":"Mazloomi S, Farimani MS, Tavilani H, Karimi J, Amiri I, Abbasi E, et al. Granulosa cells from immature follicles exhibit restricted glycolysis and reduced energy production: a dominant problem in polycystic ovary syndrome. J Assist Reprod Genet. 2023;40:343\u201359. https:\/\/doi.org\/10.1007\/s10815-022-02676-w.","journal-title":"J Assist Reprod Genet"},{"key":"2191_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13048-023-01204-3","volume":"16","author":"YK Zhao","year":"2023","unstructured":"Zhao YK, Gao YN, Wang LC, Wang J, Wang GJ, Wu HL. Correlation between abnormal energy metabolism of ovarian granulosa cells and in vitro fertilization-embryo transfer outcomes in patients with polycystic ovary syndrome and obesity. J Ovarian Res. 2023;16:145. https:\/\/doi.org\/10.1186\/s13048-023-01204-3.","journal-title":"J Ovarian Res"},{"key":"2191_CR83","doi-asserted-by":"publisher","first-page":"gaae015","DOI":"10.1093\/molehr\/gaae015","volume":"30","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Urata Y, Harada M, Kunitomi C, Kusamoto A, Koike H, et al. Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome. Mol Hum Reprod. 2024;30:gaae015. https:\/\/doi.org\/10.1093\/molehr\/gaae015.","journal-title":"Mol Hum Reprod"},{"key":"2191_CR84","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1055\/a-2280-7130","volume":"56","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhao X, Jiang T, Xi H, Jiang Y, Feng X. A Retrospective Review on Dysregulated Autophagy in Polycystic Ovary Syndrome: From Pathogenesis to Therapeutic Strategies. Horm Metab Res. 2024;56:547\u201358. https:\/\/doi.org\/10.1055\/a-2280-7130.","journal-title":"Horm Metab Res"},{"key":"2191_CR85","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.mce.2020.110792","volume":"508","author":"M Kobayashi","year":"2020","unstructured":"Kobayashi M, Yoshino O, Nakashima A, Ito M, Nishio K, Ono Y, et al. Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS\/p38 and JNK signalling during the development of polycystic ovary syndrome. Mol Cell Endocrinol. 2020;508:110792. https:\/\/doi.org\/10.1016\/j.mce.2020.110792.","journal-title":"Mol Cell Endocrinol"},{"key":"2191_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/biom15010051","volume":"15","author":"A Alhermi","year":"2025","unstructured":"Alhermi A, Perks H, Nigi V, Altahoo N, Atkin SL, Butler AE. The role of the liver in the pathophysiology of PCOS: a literature review. Biomolecules. 2025;15:51. https:\/\/doi.org\/10.3390\/biom15010051.","journal-title":"Biomolecules"},{"key":"2191_CR87","doi-asserted-by":"publisher","first-page":"103615","DOI":"10.1016\/j.redox.2025.103615","volume":"83","author":"Z Ye","year":"2025","unstructured":"Ye Z, Cheng M, Lian W, Leng Y, Qin X, Wang Y, et al. GPX4 deficiency-induced ferroptosis drives endometrial epithelial fibrosis in polycystic ovary syndrome. Redox Biol. 2025;83:103615. https:\/\/doi.org\/10.1016\/j.redox.2025.103615.","journal-title":"Redox Biol"},{"key":"2191_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12958-025-01396-x","volume":"23","author":"W Shi","year":"2025","unstructured":"Shi W, Lin H, Di W, He C, Shen Y. Granulosa cell RNA-Seq insights into senescence and sphingolipid metabolism disorder in PCOS: aspirin as a potential therapeutic drug. Reprod Biol Endocrinol. 2025;23:61. https:\/\/doi.org\/10.1186\/s12958-025-01396-x.","journal-title":"Reprod Biol Endocrinol"},{"key":"2191_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189125","volume":"26","author":"H Shigetomi","year":"2025","unstructured":"Shigetomi H, Nishio M, Umetani M, Imanaka S, Hashimoto H, Kobayashi H. Balancing decidualization, autophagy, and cellular senescence for reproductive success in endometriosis biology. Int J Mol Sci. 2025;26:9125. https:\/\/doi.org\/10.3390\/ijms26189125.","journal-title":"Int J Mol Sci"},{"key":"2191_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-026-02134-3","author":"H Kobayashi","year":"2026","unstructured":"Kobayashi H. P16 beyond senescence: cancer biology lessons applied to endometriosis. Reprod Sci. 2026. https:\/\/doi.org\/10.1007\/s43032-026-02134-3.","journal-title":"Reprod Sci"},{"key":"2191_CR91","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.22034\/APJCP.2016.17.12.5087","volume":"17","author":"AL Liu","year":"2016","unstructured":"Liu AL, Liao HQ, Li ZL, Liu J, Zhou CL, Guo ZF, et al. New insights into mTOR signal pathways in ovarian-related diseases: polycystic ovary syndrome and ovarian cancer. Asian Pac J Cancer Prev. 2016;17:5087\u201394. https:\/\/doi.org\/10.22034\/APJCP.2016.17.12.5087.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2191_CR92","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.18632\/oncotarget.2224","volume":"5","author":"XX Wang","year":"2014","unstructured":"Wang XX, Wei JZ, Jiao J, Jiang SY, Yu DH, Li D. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5:6603\u201310. https:\/\/doi.org\/10.18632\/oncotarget.2224.","journal-title":"Oncotarget"},{"key":"2191_CR93","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1093\/humrep\/det352","volume":"28","author":"FV Comim","year":"2013","unstructured":"Comim FV, Teerds K, Hardy K, Franks S. Increased protein expression of LHCG receptor and 17alpha-hydroxylase\/17-20-lyase in human polycystic ovaries. Hum Reprod. 2013;28:3086\u201392. https:\/\/doi.org\/10.1093\/humrep\/det352.","journal-title":"Hum Reprod"},{"key":"2191_CR94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","volume":"15","author":"MW Elting","year":"2000","unstructured":"Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod. 2000;15:24\u20138. https:\/\/doi.org\/10.1093\/humrep\/15.1.24.","journal-title":"Hum Reprod"},{"key":"2191_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-023-01334-8","volume":"17","author":"NX Jiang","year":"2024","unstructured":"Jiang NX, Zhao WJ, Shen HR, Du DF, Li XL. Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility. J Ovarian Res. 2024;17:31. https:\/\/doi.org\/10.1186\/s13048-023-01334-8.","journal-title":"J Ovarian Res"},{"key":"2191_CR96","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"W Ye","year":"2021","unstructured":"Ye W, Xie T, Song Y, Zhou L. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021;25:1825\u201337. https:\/\/doi.org\/10.1111\/jcmm.16205.","journal-title":"J Cell Mol Med"},{"key":"2191_CR97","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/oxfordjournals.humrep.a137577","volume":"7","author":"R Homburg","year":"1992","unstructured":"Homburg R, Pariente C, Lunenfeld B, Jacobs HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod. 1992;7:1379\u201383. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137577.","journal-title":"Hum Reprod"},{"key":"2191_CR98","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, et al. Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci. 2017;24:646\u201355. https:\/\/doi.org\/10.1177\/1933719116667606.","journal-title":"Reprod Sci"},{"key":"2191_CR99","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cmet.2014.09.013","volume":"20","author":"DG Hardie","year":"2014","unstructured":"Hardie DG. AMPK\u2013sensing energy while talking to other signaling pathways. Cell Metab. 2014;20:939\u201352. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.013.","journal-title":"Cell Metab"},{"key":"2191_CR100","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12291-023-01139-y","volume":"39","author":"AT Jalil","year":"2024","unstructured":"Jalil AT, Zair MA, Hanthal ZR, Naser SJ, Aslandook T, Abosaooda M, et al. Role of the AMP-activated protein kinase in the pathogenesis of polycystic ovary syndrome. Indian J Clin Biochem. 2024;39:450\u20138. https:\/\/doi.org\/10.1007\/s12291-023-01139-y.","journal-title":"Indian J Clin Biochem"},{"key":"2191_CR101","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/MCB.06159-11","volume":"32","author":"S Alers","year":"2012","unstructured":"Alers S, L\u00f6ffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32:2\u201311. https:\/\/doi.org\/10.1128\/MCB.06159-11.","journal-title":"Mol Cell Biol"},{"key":"2191_CR102","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/biolre\/ioab078","volume":"105","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang Q, Wang H, Zhu J, Cong L, Li H, et al. NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndrome. Biol Reprod. 2021;105:371\u201380. https:\/\/doi.org\/10.1093\/biolre\/ioab078.","journal-title":"Biol Reprod"},{"key":"2191_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.05.010","volume":"187","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Ren J, Wang F, Pan M, Cui L, Li M, et al. Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3. Free Radic Biol Med. 2022;187:1\u201316. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.05.010.","journal-title":"Free Radic Biol Med"},{"key":"2191_CR104","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12905-022-01912-w","volume":"22","author":"Q Wang","year":"2022","unstructured":"Wang Q, Fang C, Zhao Y, Liu Z. Correlation study on serum miR-222-3p and glucose and lipid metabolism in patients with polycystic ovary syndrome. BMC Womens Health. 2022;22:398. https:\/\/doi.org\/10.1186\/s12905-022-01912-w.","journal-title":"BMC Womens Health"},{"key":"2191_CR105","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1210\/endo.137.10.8828504","volume":"137","author":"T Sasaoka","year":"1996","unstructured":"Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, et al. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Endocrinology. 1996;137:4427\u201334. https:\/\/doi.org\/10.1210\/endo.137.10.8828504.","journal-title":"Endocrinology"},{"key":"2191_CR106","doi-asserted-by":"publisher","first-page":"14892","DOI":"10.1038\/ncomms14892","volume":"8","author":"W Cai","year":"2017","unstructured":"Cai W, Sakaguchi M, Kleinridders A, Gonzalez-Del Pino G, Dreyfuss JM, O\u2019Neill BT, et al. Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nat Commun. 2017;8:14892. https:\/\/doi.org\/10.1038\/ncomms14892.","journal-title":"Nat Commun"},{"key":"2191_CR107","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10735-022-10096-4","volume":"53","author":"F Wang","year":"2022","unstructured":"Wang F, Han J, Wang X, Liu Y, Zhang Z. Roles of HIF-1alpha\/BNIP3 mediated mitophagy in mitochondrial dysfunction of letrozole-induced PCOS rats. J Mol Histol. 2022;53:833\u201342. https:\/\/doi.org\/10.1007\/s10735-022-10096-4.","journal-title":"J Mol Histol"},{"key":"2191_CR108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/REP-17-0499","volume":"155","author":"D Li","year":"2018","unstructured":"Li D, You Y, Bi FF, Zhang TN, Jiao J, Wang TR, et al. Autophagy is activated in the ovarian tissue of polycystic ovary syndrome. Reproduction. 2018;155:85\u201392. https:\/\/doi.org\/10.1530\/REP-17-0499.","journal-title":"Reproduction"},{"key":"2191_CR109","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00441-023-03747-9","volume":"392","author":"C Xu","year":"2023","unstructured":"Xu C, Luo M, Liu X, Wei T, Zhou Z, Li C, et al. MicroRNA-1298-5p in granulosa cells facilitates cell autophagy in polycystic ovary syndrome by suppressing glutathione-disulfide reductase. Cell Tissue Res. 2023;392:763\u201378. https:\/\/doi.org\/10.1007\/s00441-023-03747-9.","journal-title":"Cell Tissue Res"},{"key":"2191_CR110","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13048-025-01817-w","volume":"18","author":"X Ouyang","year":"2025","unstructured":"Ouyang X, Zhou Q, Tang H, Li L. Pathogenesis and treatment of obesity-related polycystic ovary syndrome. J Ovarian Res. 2025;18:258. https:\/\/doi.org\/10.1186\/s13048-025-01817-w.","journal-title":"J Ovarian Res"},{"key":"2191_CR111","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18632\/aging.100444","volume":"4","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging. 2012;4:166\u201375. https:\/\/doi.org\/10.18632\/aging.100444.","journal-title":"Aging"},{"key":"2191_CR112","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi J. d\u2019Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729\u201340. https:\/\/doi.org\/10.1038\/nrm2233.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2191_CR113","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00404-023-07025-5","volume":"309","author":"AG Miranda","year":"2024","unstructured":"Miranda AG, Seneda MM, Faustino LR. DNA methylation associated with polycystic ovary syndrome: a systematic review. Arch Gynecol Obstet. 2024;309:373\u201383. https:\/\/doi.org\/10.1007\/s00404-023-07025-5.","journal-title":"Arch Gynecol Obstet"},{"key":"2191_CR114","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00404-025-08048-w","volume":"312","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Ding J, Xia F. DNA methylation and its impact on ovarian steroidogenesis in women with polycystic ovary syndrome: insights from human and animal models. Arch Gynecol Obstet. 2025;312:363\u201374. https:\/\/doi.org\/10.1007\/s00404-025-08048-w.","journal-title":"Arch Gynecol Obstet"},{"key":"2191_CR115","doi-asserted-by":"publisher","first-page":"664843","DOI":"10.3389\/fcell.2021.664843","volume":"9","author":"P Cao","year":"2021","unstructured":"Cao P, Yang W, Wang P, Li X, Nashun B. Characterization of DNA methylation and screening of epigenetic markers in polycystic ovary syndrome. Front Cell Dev Biol. 2021;9:664843. https:\/\/doi.org\/10.3389\/fcell.2021.664843.","journal-title":"Front Cell Dev Biol"},{"key":"2191_CR116","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000529354","volume":"88","author":"Y Fu","year":"2023","unstructured":"Fu Y, Sun Q, Zhu K, Hu C. Elevated insulin-like growth factor-1-induced female rats perpetuate the polycystic ovary syndrome phenotype: pathological mechanism of insulin-like growth factor-1 in polycystic ovary syndrome. Gynecol Obstet Invest. 2023;88:143\u20139. https:\/\/doi.org\/10.1159\/000529354.","journal-title":"Gynecol Obstet Invest"},{"key":"2191_CR117","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.arcmed.2021.01.008","volume":"52","author":"J Mu","year":"2021","unstructured":"Mu J, Yu P, Li Q. microRNA-103 contributes to progression of polycystic ovary syndrome through modulating the IRS1\/PI3K\/AKT signal axis. Arch Med Res. 2021;52:494\u2013504. https:\/\/doi.org\/10.1016\/j.arcmed.2021.01.008.","journal-title":"Arch Med Res"},{"key":"2191_CR118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0.","journal-title":"J Ovarian Res"},{"key":"2191_CR119","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s43032-022-01100-z","volume":"30","author":"J Finsterer","year":"2023","unstructured":"Finsterer J. Mitochondrial dysfunction in polycystic ovary syndrome. Reprod Sci. 2023;30:1435\u201342. https:\/\/doi.org\/10.1007\/s43032-022-01100-z.","journal-title":"Reprod Sci"},{"key":"2191_CR120","doi-asserted-by":"publisher","first-page":"112386","DOI":"10.1016\/j.mce.2024.112386","volume":"594","author":"SP Tharayil","year":"2024","unstructured":"Tharayil SP, Rasal S, Gawde U, Mukherjee S, Patil A, Joshi B, et al. Relation of mitochondrial DNA copy number and variants with the clinical characteristics of polycystic ovary syndrome. Mol Cell Endocrinol. 2024;594:112386. https:\/\/doi.org\/10.1016\/j.mce.2024.112386.","journal-title":"Mol Cell Endocrinol"},{"key":"2191_CR121","doi-asserted-by":"publisher","first-page":"789008","DOI":"10.3389\/fendo.2022.789008","volume":"13","author":"L Song","year":"2022","unstructured":"Song L, Yu J, Zhang D, Li X, Chen L, Cai Z, et al. Androgen excess induced mitochondrial abnormality in ovarian granulosa cells in a rat model of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13:789008. https:\/\/doi.org\/10.3389\/fendo.2022.789008.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR122","doi-asserted-by":"publisher","first-page":"e250186","DOI":"10.1530\/EC-25-0186","volume":"14","author":"X Yan","year":"2025","unstructured":"Yan X, Ma D, Li R, Xu J, Zou Y, He M. The role of mitochondrial dysfunction in ovarian granulosa cells in polycystic ovary syndrome. Endocr Connect. 2025;14:e250186. https:\/\/doi.org\/10.1530\/EC-25-0186.","journal-title":"Endocr Connect"},{"key":"2191_CR123","doi-asserted-by":"publisher","first-page":"gaaf058","DOI":"10.1093\/molehr\/gaaf058","volume":"32","author":"BG Edepli","year":"2026","unstructured":"Edepli BG, Yaba A. Molecular mechanisms of ovarian fibrosis. Mol Hum Reprod. 2026;32:gaaf058. https:\/\/doi.org\/10.1093\/molehr\/gaaf058.","journal-title":"Mol Hum Reprod"},{"key":"2191_CR124","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1530\/REP-17-0597","volume":"155","author":"M Di Pietro","year":"2018","unstructured":"Di Pietro M, Pascuali N, Parborell F, Abramovich D. Ovarian angiogenesis in polycystic ovary syndrome. Reproduction. 2018;155:R199\u2013209. https:\/\/doi.org\/10.1530\/REP-17-0597.","journal-title":"Reproduction"},{"key":"2191_CR125","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/humrep\/dev055","volume":"30","author":"TT Piltonen","year":"2015","unstructured":"Piltonen TT, Chen JC, Khatun M, Kangasniemi M, Liakka A, Spitzer T, et al. Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro. Hum Reprod. 2015;30:1203\u201315. https:\/\/doi.org\/10.1093\/humrep\/dev055.","journal-title":"Hum Reprod"},{"key":"2191_CR126","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ijms25021203","volume":"25","author":"S Matsuyama","year":"2024","unstructured":"Matsuyama S, Whiteside S, Li SY. Implantation and decidualization in PCOS: unraveling the complexities of pregnancy. Int J Mol Sci. 2024;25:1203. https:\/\/doi.org\/10.3390\/ijms25021203.","journal-title":"Int J Mol Sci"},{"key":"2191_CR127","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1210\/jc.2013-1923","volume":"98","author":"TT Piltonen","year":"2013","unstructured":"Piltonen TT, Chen J, Erikson DW, Spitzer TL, Barragan F, Rabban JT, et al. Mesenchymal stem\/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. J Clin Endocrinol Metab. 2013;98:3765\u201375. https:\/\/doi.org\/10.1210\/jc.2013-1923.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR128","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.reth.2024.08.016","volume":"26","author":"F Kouchakzadeh","year":"2024","unstructured":"Kouchakzadeh F, Ebrahimi-Barough S, Aflatoonian B, Ai J, Mazaheri F, Montazeri F, Hajizadeh-Tafti F, et al. Therapeutic potential of endometrial stem cells encapsulated in alginate\/gelatin hydrogel to treat of polycystic ovary syndrome. Regen Ther. 2024;26:693\u2013707. https:\/\/doi.org\/10.1016\/j.reth.2024.08.016.","journal-title":"Regen Ther"},{"key":"2191_CR129","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1111\/jog.16136","volume":"50","author":"H Noguchi","year":"2024","unstructured":"Noguchi H, Iwasa T, Iwase A, Kanasaki H, Kimura F, Kugu K, et al. Phenotypes and clinical laboratory data for polycystic ovary syndrome cases: A nationwide survey in Japan. J Obstet Gynaecol Res. 2024;50:2346\u201356. https:\/\/doi.org\/10.1111\/jog.16136.","journal-title":"J Obstet Gynaecol Res"},{"key":"2191_CR130","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1210\/jcem.85.11.6992","volume":"85","author":"CA Agleson","year":"2000","unstructured":"1agleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 2000;85:4047\u201352. https:\/\/doi.org\/10.1210\/jcem.85.11.6992.","journal-title":"J Clin Endocrinol Metab"},{"key":"2191_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13643-019-0962-3","volume":"8","author":"C Kite","year":"2019","unstructured":"Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev. 2019;8:51. https:\/\/doi.org\/10.1186\/s13643-019-0962-3.","journal-title":"Syst Rev"},{"key":"2191_CR132","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/life12020308","volume":"12","author":"CH Kim","year":"2022","unstructured":"Kim CH, Lee SH. Effectiveness of lifestyle modification in polycystic ovary syndrome patients with obesity: a systematic review and meta-analysis. Life (Basel). 2022;12:308. https:\/\/doi.org\/10.3390\/life12020308.","journal-title":"Life (Basel)"},{"key":"2191_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00606","volume":"11","author":"RK Patten","year":"2020","unstructured":"Patten RK, Boyle RA, Moholdt T, Kiel I, Hopkins WG, Harrison CL, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11:606. https:\/\/doi.org\/10.3389\/fphys.2020.00606.","journal-title":"Front Physiol"},{"key":"2191_CR134","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1507\/endocrj.EJ21-0480","volume":"69","author":"B Xu","year":"2022","unstructured":"Xu B, Dai W, Liu L, Han H, Zhang J, Du X, et al. Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K\/AKT\/mTOR pathway. Endocr J. 2022;69:863\u201375. https:\/\/doi.org\/10.1507\/endocrj.EJ21-0480.","journal-title":"Endocr J"},{"key":"2191_CR135","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub6","volume":"11","author":"LC Morley","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11:CD003053. https:\/\/doi.org\/10.1002\/14651858.CD003053.pub6.","journal-title":"Cochrane Database Syst Rev"},{"key":"2191_CR136","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","volume":"327","author":"JM Lord","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327:951\u20133. https:\/\/doi.org\/10.1136\/bmj.327.7421.951.","journal-title":"BMJ"},{"key":"2191_CR137","doi-asserted-by":"publisher","unstructured":"Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev. 2003;3CD003053. https:\/\/doi.org\/10.1002\/14651858.CD003053.","DOI":"10.1002\/14651858.CD003053"},{"key":"2191_CR138","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","volume":"39","author":"Y Han","year":"2019","unstructured":"Han Y, Li Y, He B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39:332\u201342. https:\/\/doi.org\/10.1016\/j.rbmo.2019.04.017.","journal-title":"Reprod Biomed Online"},{"key":"2191_CR139","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1017\/S0967199424000388","volume":"32","author":"E Yildirim","year":"2024","unstructured":"Yildirim E, Onel T, Agus S, Gunalan E, Yilmaz B, Aydin MS, et al. The effect of rapamycin treatment on mouse ovarian follicle development in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model. Zygote. 2024;32:386\u201395. https:\/\/doi.org\/10.1017\/S0967199424000388.","journal-title":"Zygote"},{"key":"2191_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.23768","volume":"91","author":"R Jin","year":"2024","unstructured":"Jin R, Chen A, Ye Y, Ren Y, Lu J, Xuan F, et al. Effect of berberine combined with metformin on autophagy in polycystic ovary syndrome by regulating AMPK\/AKT\/mTOR pathway. Mol Reprod Dev. 2024;91:e23768. https:\/\/doi.org\/10.1002\/mrd.23768.","journal-title":"Mol Reprod Dev"},{"key":"2191_CR141","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2565437","volume":"57","author":"X Xin","year":"2025","unstructured":"Xin X, Dong L, Li J, Zhang J, Wu H. Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective. Ann Med. 2025;57:2565437. https:\/\/doi.org\/10.1080\/07853890.2025.2565437.","journal-title":"Ann Med"},{"key":"2191_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01220-y","volume":"22","author":"P Su","year":"2024","unstructured":"Su P, Chen C, Pang L, Wu K, Sun Y. Effects of quercetin on polycystic ovary syndrome in animal models: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2024;22:46. https:\/\/doi.org\/10.1186\/s12958-024-01220-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"2191_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1070264","volume":"14","author":"Q Peng","year":"2023","unstructured":"Peng Q, Chen X, Liang X, Ouyang J, Wang Q, Ren S, et al. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis. Front Endocrinol (Lausanne). 2023;14:1070264. https:\/\/doi.org\/10.3389\/fendo.2023.1070264.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2191_CR144","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. MTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004.","journal-title":"Cell"},{"key":"2191_CR145","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13048-024-01422-3","volume":"17","author":"A Abdi","year":"2024","unstructured":"Abdi A, Ranjbaran M, Amidi F, Akhondzadeh F, Seifi B. The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway. J Ovarian Res. 2024;17:91. https:\/\/doi.org\/10.1186\/s13048-024-01422-3.","journal-title":"J Ovarian Res"},{"key":"2191_CR146","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S574044","volume":"21","author":"P Liu","year":"2026","unstructured":"Liu P, Sha Y, Yang H, Liu T. Exosomes for polycystic ovary syndrome treatment: mechanisms and therapeutic potential. Int J Nanomedicine. 2026;21:574044. https:\/\/doi.org\/10.2147\/IJN.S574044.","journal-title":"Int J Nanomedicine"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02191-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:45:12Z","timestamp":1791387912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02191-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":146,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02191-8","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}